Susan Hogarth
Overcoming Anxiety with Peptides

Living With Lifelong Anxiety and Finding an Unexpected Solution in a Peptide (Say What!!)

I believe I have lived with anxiety for as long as I can remember. Growing up in a dangerous household meant I learned early how to hide my fear, often numbing it with alcohol and drugs. When I got sober over seventeen years ago, my anxiety didn’t magically disappear. In fact, without substances masking it, the anxiety became physically overwhelming. Anyone who struggles with anxiety knows that rush: the pounding heart, the sinking sensation sliding down your body, the sudden sense of losing control.

During COVID, my mental health worsened, something many people experienced during and after lockdown. I was prescribed medication, and while it helped temporarily, every conversation with a doctor seemed to end with the same solution: more medication. As someone who didn’t even take vitamins before the pandemic, I wanted to reduce my medications, not add to them.

That’s when a different option was offered: Selank peptide. Selank is a synthetic analog of the naturally occurring human peptide tuftsin (Ashmarin et al., 1998). Research suggests that Selank may reduce anxiety and support cognitive function, in part through modulation of neurotransmitter systems. For example, Zhuravleva et al. (2015) found that Selank modulates GABAergic activity, which may contribute to its mild tranquillizing effects. Simply put (because I am not that scientifically sexy), GABAergic activity refers to the way the brain uses the calming neurotransmitter GABA to help reduce stress and maintain nervous system balance (Nutt & Malizia, 2001).

For me, it felt like a miracle. The first time I administered it, my symptoms faded within minutes, and for the rest of the day, I practically forgot I had anxiety at all. Since then, Selank has become part of my daily routine. At first, I only used it as needed. But the more I learned about peptides, the more I understood that consistency matters; their effects build gradually as they help balance neurotransmitters over time.

More importantly, Selank doesn’t sedate me or make me feel “drugged,” like medications such as Ativan or Quetiapine. Those can offer immediate calming effects but also carry risks such as dependence, memory impairment, withdrawal, and yes, even the next-day medication hangover. These risks are especially concerning for someone in recovery from substance use disorder (Lader, 2011). And as many people know, medications can also bring side effects and long adjustment periods.

Selank works differently. It helps me regulate anxiety without causing sedation, emotional blunting, or addictive potential. For me, it provides a clearer, calmer sense of relief through gentle neuromodulation; basically, helping the brain adjust its own signals, rather than chemically overriding it.

Peptides are not medications in the conventional sense; they act as signals within the body rather than forcing chemical change. Selank has offered me something I had never experienced before: relief from lifelong anxiety without compromising my recovery, my clarity, or my sense of self.

If you’d like to learn more or talk about how this has helped me press the button below or leave a comment on the discussion board.

2 responses to “Overcoming Anxiety with Peptides”

  1. Danielle Avatar
    Danielle

    Thank you for this article. Where would someone find a safe and high quality source to try this particular peptide?

  2. Key Avatar
    Key

    Thank you for sharing your personal experience with Selank peptide – it’s fascinating to hear how peptides can offer anxiety relief without the side effects of traditional medications. Your mention of Selank’s neuromodulatory effects made me curious about other neurological applications of peptides.

    I recently came across an interesting article discussing peptides for cognitive issues like brain fog at https://mindbodyneurology.com/peptides-and-brain-fog-integrative-neurology/. Have you or other readers explored peptides for neurological benefits beyond anxiety management? I’d be curious to hear if anyone has experience with peptides helping with focus, memory, or other cognitive functions in addition to anxiety relief.

Leave a Reply

Your email address will not be published. Required fields are marked *


References

Ashmarin, I. P., Kamensky, A. A., Yutanova, N. V., & Lyapina, L. A. (1998). Tuftsin and its synthetic derivatives: Pharmacology and therapeutic potential. Advances in Experimental Medicine and Biology, 437, 109–118.

Lader, M. (2011). Benzodiazepines revisited—Will we ever learn? Addiction, 106(12), 2086–2109. https://doi.org/10.1111/j.1360-0443.2011.03563.x

Nutt, D. J., & Malizia, A. L. (2001). New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. The British Journal of Psychiatry, 179(5), 390–396. https://doi.org/10.1192/bjp.179.5.390

Zhuravleva, O. A., Zakirova, N. F., Rizvanov, A. A., & Salafutdinov, I. I. (2015). Selank enhances the anti-anxiety effect by modulating the GABAergic system. Bulletin of Experimental Biology and Medicine, 158(6), 766–768.

Journey
Protected: Latchkey Kid

This content is password-protected. To view it, please enter the password below.

Addiction Treatment Models

The following paper aims to inform the reader of the current addiction treatment models in Portugal and specific European countries to compare addiction treatment and recovery solutions.  The document includes an overview of presentations on drug consumption and harm reduction models and reviews the decriminalization laws in Portugal.  Furthermore, the document includes information based on the public perception of substance use and addiction in the city is Lisbon.  Additionally, there is an overview of residential treatment, bed-based programs, therapeutic communities, treatments in the prison system and drug consumption in Europe, including Lisbon, Slovenia, Zurich, Ljubljana, Kyiv and the Czech Republic. Read

Addiction: Historical Facts

Stigma

Over a thousand years ago, excessive alcohol use and drunkenness were recognized as a social problem. However, the definition of perpetual drunkenness and its consequences was not established medically until the 18th century when the term alcoholism was coined. Historically, alcoholism was known to cause social disapproval (stigma) of alcoholics caused by misguided views of alcoholism. In the early 1900s, Individuals with alcoholism were described as morally inferior, and children of alcoholics were often labelled born criminals with no ability to determine right from wrong.

Opiates Kill Crying Babies

A draft of opium was given to crying babies in Ancient Egypt and the Victorian era. A concoction like “Mrs. Winslows Soothing Syrup” often contained morphine, opium and other ingredients. It was used to settle restless babies and had been described historically as the “Poor Child’s Nurse” because of its ability to stop babies from crying. The poisonous concoction caused infant mortality from starvation because the babies were in a continued state of narcotism and declined food.

There have been many treatments to curb the appetite for addiction and alcoholism throughout recorded history. In the 1600s, smokers in Russia were punished by lip cutting, and those who smoked hashish in Egypt had their teeth pulled out. Alcoholics were perceived as individuals of low character; some were jailed, tortured, and executed for being possessed by demons while in a state of addiction.

19th Century Quackery

A nation corrupted by alcohol can never be free.” ~ Dr. Benjamin Rush

The 19th century fashioned many medical claims involving alcohol prescribed as a treatment for ailments, and it was often sold as a safer and cleaner water source. As a result, drugs with mind-altering effects seem to flow perpetually back and forth between good and bad, medicine and poison. Dr. Benjamin Rush was one of the first doctors to suggest that a treatment for addicts with the progressive & incurable disease of addiction was to go away somewhere to sober up and “kick the habit.” Rush’s philosophy ultimately shaped how many doctors treat SUD today.

The Keeley Cure

In the 1800s, treatment regimens involved isolation and “detoxification,” a slightly dangerous process involving administering poison. In late 1800, Dr. Leslie E. Keeley began searching for a cure for addiction. The Keeley Cure was a useless injection; however, the cure had a surprising 50% success rate because, besides the seemingly useless injections, Dr. Keeley encouraged group therapy, exchanging information, and getting community involvement. Over 100 years later, group therapy, exchange of information and community involvement are treatment strategies learned, taught, and implemented as a part of abstinence-based recovery.

In the 21st Century, alcoholism clinical diagnostic terms such as alcohol use disorder or alcohol dependence replaced the use of alcoholism and alcoholic because the terms alcoholism and alcoholic were determined to be stigmatizing and discouraged alcoholics from seeking treatment. Alcohol use disorder is among the most highly stigmatized medical conditions in the Western world, contributing to significant social and economic losses to individuals and society at large.

History that Keeps on Giving

Charles Schuppert used morphine as a wonder drug. He injected patients with the medication to relieve pain, asthma, headaches, alcoholics’ delirium tremors, gastrointestinal diseases and menstrual cramps. Physicians prescribed opiates, and pharmacists sold them to individuals medicating themselves for physical and mental discomforts, causing dependency. By 1895, morphine and opium powders had led to an addiction epidemic that affected roughly 1 in 200 Americans and, in some cities, made up 15% of all dispensed medications.

One hundred twenty years later, a wave of prescribed medical opiates has been described as sinister and dubbed the “crime of the century.” OxyContin (oxycodone), a semisynthetic narcotic analgesic, is prescribed for the management of moderate to severe pain, chronic pain syndromes, and terminal cancers. The manufacturer, Purdue Pharma, owned by the Sackler family members, unleashed an aggressive promotion of the highly addictive OxyContin that laid the groundwork for America’s opioid crisis that killed more than 100,000 people in 2022.  However, these medical opiates were approved and prescribed by physicians as it has been historically. 

Light & Dark Mode

Primary Color

Secondary Color

Layout Mode